v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net cash provided by operating activities (Note 5) $ 568,922 $ 1,063,833 $ 754,887
Cash flows from investing activities:      
Capital expenditures (153,679) (196,563) (207,404)
Origination of finance receivables held for investment (2,553,575) (3,639,279) (3,873,542)
Collections of finance receivables held for investment 2,650,199 3,440,340 3,570,822
Proceeds from sale of finance receivables initially held for investment 3,685,613 0 0
Proceeds from sale of securitization beneficial interests, net 125,369 0 0
Collections of retained securitization beneficial interests 23,722 0 0
Other investing activities 1,126 12,172 (2,180)
Net cash provided (used) by investing activities 3,778,775 (383,330) (512,304)
Cash flows from financing activities:      
Proceeds from issuance of medium-term notes 647,088 495,856 1,446,304
Repayments of medium-term notes (1,815,368) (660,780) (1,056,680)
Proceeds from term loan 448,013 0 0
Repayment of term loan (450,000) 0 0
Repayment of senior unsecured notes (450,000) 0 0
Proceeds from securitization debt 497,790 1,145,211 1,045,547
Repayments of securitization debt (781,141) (1,078,248) (1,193,526)
Borrowings of asset-backed commercial paper 155,000 469,986 42,429
Repayments of asset-backed commercial paper (671,526) (258,077) (237,370)
Net (decrease) increase in unsecured commercial paper (141,600) (237,340) 107,146
Capital contribution from third parties 46,600 0 0
Net (decrease) increase in deposits (14,711) 102,119 129,855
Dividends paid (86,388) (91,224) (96,310)
Repurchase of common stock (353,270) (459,829) (363,987)
Share repurchases not yet settled (40,000) 0 0
Other financing activities (787) 11 1,946
Net cash used by financing activities (3,010,300) (572,315) (174,646)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 13,493 (16,145) 1,697
Net increase in cash, cash equivalents and restricted cash 1,350,890 92,043 69,634
Cash, cash equivalents and restricted cash, beginning of period 1,740,854 1,648,811 1,579,177
Net increase in cash, cash equivalents and restricted cash 1,350,890 92,043 69,634
Cash, cash equivalents and restricted cash, end of period 3,091,744 1,740,854 1,648,811
Reconciliation of cash, cash equivalents and restricted cash on the Consolidated balance sheets to the Consolidated statements of cash flows:      
Cash and cash equivalents 3,091,744 1,589,608 1,533,806
Restricted cash 0 135,661 104,642
Restricted cash included in Other long-term assets 0 15,585 10,363
Cash, cash equivalents and restricted cash per the Consolidated statements of cash flows $ 3,091,744 $ 1,740,854 $ 1,648,811